Javeri Fiscal Services Ltd.

About Javeri

Equity

Derivatives

Mutual Funds

IPO

Corporate Info

Research

Corporate Info

Smart Quotes

Company Background

Board of Directors

Balance Sheet

Profit & Loss

Peer Comparison

Cash Flow

Shareholdings Pattern

Quarterly Results

Share Price

Deliverable Volume

Historical Volume

MF Holdings

Financial Ratios

Directors Report

Price Charts

Beta Analysis

Board Meetings

Corporate Announcements

Book Closure

Bonus

Company News

Dividend Details

Bulk Deals

Insider Trading

Advanced Chart

HOME > CORPORATE INFO > SMART QUOTES

Smart Quotes

Dr. Reddy's Laboratories Ltd.

Industry : Pharmaceuticals & Drugs

BSE Code	500124
ISIN Demat	INE089A01031
Book Value	322.47

NSE Code	DRREDDY
Dividend Yield %	0.60
Market Cap	1120172.45

P/E	23.29
EPS	57.64
Face Value	1


	BSE		NSE

20-Dec-2024

Last Price	1342.45
Net Change	16.45
% Change	1.24%
Prev.Close	1326.00
Open	1328.95
High	1368.00
Low	1318.35
Volume	206466

Last Price	1343.65
Net Change	18.05
% Change	1.36%
Prev.Close	1325.60
Open	1326.00
High	1368.70
Low	1317.40
Volume	7499087

Value	279184255
Best Buy	0.00
Best Sell	0.00
Best Quantity	0
Sell Quantity	0
Today's Range	1368.00
52-Week High	1420.20
52-Week Low	1094.88

Value	10143828011.7
Best Buy	1343.65
Best Sell	0.00
Best Quantity	25
Sell Quantity	0
Today's Range	1368.70
52-Week High	1421.49
52-Week Low	1094.24

Open Price	1318.10
High Price	1358.60
Low Price	1311.75
Last Price	1345.15
Prev Close	1318.20
Change	26.95
% Change	2.04 %

Average Price	1348.42
Underlying Value	1343.65
Number of contracts traded	20111
Turnover in Rs. Lakhs	169488
Open Interest	7653125.00
Change in O I	-3166255.00
% Change in O I	-29.26 %

Today

You need to upgrade your Flash Player

Best Bid

Best Offer

Quantity	0
Price	0.00

Quantity	0
Price	0.00

Best Bid

Best Offer

Quantity	25
Price	1343.65

Quantity	0
Price	0.00

Best Bid

Best Offer

Quantity	625
Price	1340.15

Quantity	1250
Price	1342.6

Holding Details

Latest Corporate Events

Bonus

1 : 1

28-Aug-06

Book Closure

17-Jul-24

19-Jul-24

Dividend

800 %

17-Jul-24

Company News

20-12-2024

Dr. Reddy’s Laboratories ...

20-12-2024

Dr. Reddy’s Laboratories ...

28-11-2024

Dr. Reddy’s Laboratories ...

28-11-2024

Dr. Reddy’s Laboratories ...

26-11-2024

Dr.Reddy's Laboratories i...

26-11-2024

Dr.Reddy's Laboratories i...

18-11-2024

Dr. Reddy's Laboratories’...

Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source: Click Here.